Pelioid-type hepatocellular carcinoma with numerous eosinophilic infiltrations in a patient with primary biliary cirrhosis

Hepatology Research

Volumn 38, Issue 4, 2008, Pages 421-427

  Watanabe, Takuya ^a   Aikawa, Keiko ^b   Kanefuji, Tsutomu ^a   Yamazaki, Kazuhide ^a   Hirono, Haruka ^a   Hasegawa, Katsuhiko ^a   Soga, Kenji ^a   Shibasaki, Koichi ^a   Umezu, Hajime ^c   Nomoto, Minoru ^c  

^a NIPPON DENTAL UNIVERSITY   (Japan)

^b Aikawa Station Clinic   (Japan)

^c NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Eosinophilic infiltration; Hepatocellular carcinoma; Pelioid type; Primary biliary cirrhosis

Indexed keywords

ALPHA FETOPROTEIN; URSODEOXYCHOLIC ACID; ZINOSTATIN MALEIC ACID STYRENE COPOLYMER;

AGED; ANGIOGRAPHY; ARTICLE; CANCER RELAPSE; CANCER SIZE; CASE REPORT; CAUSE OF DEATH; CELL INFILTRATION; DISEASE CLASSIFICATION; DISEASE COURSE; EOSINOPHIL; FEMALE; HISTOPATHOLOGY; HUMAN; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER INJURY; LIVER RESECTION; PATIENT REFERRAL; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL;

EID: 40049102817     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2007.00277.x     Document Type: Article

References (40)

1. Kaplan MM. Primary biliary cirrhosis. N Engl J Med 1996; 335: 1570-81.
2. Loof L, Adami HO, Sparen P etal. Cancer risk in primary biliary cirrhosis: A population-based study from Sweden. Hepatology 1994; 20: 101-4.
3. Turissini SB, Kaplan MM. Hepatocellular carcinoma in primary biliary cirrhosis. Am J Gastroenterol 1997; 92: 676-8.
4. Floreani A, Biagini MR, Chiaramonte M, Milani S, Surrenti C, Naccarato R. Incidence of hepatic and extra-hepatic malignancies in primary biliary cirrhosis (PBC). Ital J Gastroenterol 1993; 25: 473-6.
5. Maruyama H, Iwamura S, Watanabe S. [Three autopsy cases of hepatocellular carcinoma arising from primary biliary cirrhosis (PBC).] Okayama Igakkai Zasshi 1999; 102: 261-3. (In Japanese.)
6. Shibuya A, Tanaka K, Miyakawa H et al. Hepatocellular carcinoma and survival in patients with primary biliary cirrhosis. Hepatology 2002; 35: 1172-8.
7. Takagi F, Takahashi A, Yokoyama T. [An autopsy case of the hepatocellular carcinoma arising from primary biliary cirrhosis.] Byori Rinsho 1985; 3: 664-8. (In Japanese.)
8. Gibson JB, Sobin LH. WHO Histological Typing of Tumors of the Liver, Biliary Tract and Pancreas. Geneva: World Health Organization, 1978; 13-30.
9. Antonio C, Louise MR, Yogeshwar D, Barbara CW, Geoffrey F. Morphology and other prognostic factors of hepatocellular carcinoma. Arch Pathol Lab Med 1999; 123: 524-8.
10. Adachi E, Maeda T, Kajiyama K etal. Factors correlated with portal venous invasion by hepatocellular carcinoma. Cancer 1996; 77: 2022-31.
11. Caballeria L, Pares A, Castells A, Gines A, Bru C, Rodes J. Hepatocellular carcinoma in primary biliary cirrhosis: Similar incidence to that in hepatitis C virus-related cirrhosis. Am J Gastroenterol 2001; 96: 1160-3.
12. urohiji T. [An experimental study of ethanol injection of VX2 liver cancer.] Kanzo 1989; 30: 545-52. (In Japanese.)
13. Yoshida T, Kanai T, Monden M etal. Immunological and histological analysis of transarterial immuno-embolozation therapy (TIE) in operable patients with hepatocellular carcinoma (in Japanese with English abstract). Gan To Kagakuryoho (Jpn J Cancer Chemother) 1994; 21: 2111-14.
14. Paradinas FJ, Bull TB, Westby D, Murray-Lyon IM. Hyperplasia and prolapsed of hepatocytes into hepatic veins during longterm methyltestosterone therapy: Possible relationships of these changes to the development of peliosis hepatis and liver tumors. Histopathology 1977; 1: 225-46.
15. Degott C, Rueff B, Kreis A, Duboust A, Potet F, Benhamou JP. Peliosis hepatis in recipients of renal transplants. Gut 1978; 19: 748-53.
16. Tanaka S, Mori M, Sakamoto Y et al. Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma. J Clin Invest 1999; 103: 341-5.
17. Sugimachi K, Tanaka S, Taguchi K, Aishima S, Shimada M, Tsuneyoshi M. Angiopoietin switching regulates angiogenesis and progression of human hepatocellular carcinoma. J Clin Pathol 2003; 56: 854-60.
18. Yamamoto T, Fukuura T, Kitagawa T, Matsumoto K, Iriyama K. A case of hepatocellular carcinoma resembling giant hemangioma which developed during pregnancy. J Jpn Surg Assoc 1995; 56: 2412-16.
19. Shimizu S, Kamiike W, Ito T et al. A case report of giant hepatocellular carcinoma which was difficult to differentially diagnose from hepatic hemangioma. J Jpn Surg Assoc 1994; 55: 974-7.
20. Ji EK, Ryu JS, Kang GH, Moon DH, Auh YH, Lee HK. Pelioid-type hepatocellular carcinoma masquerading as a hepatic hemangioma on technetium-99m red blood cell scintigraphy. Clin Nucl Med 2001; 26: 33-5.
21. Lim ST, Sohn MH. A case of hepatocellular carcinoma mimicking cavernous hemangioma on Tc-99m RBC liver SPECT. Clin Nucl Med 2001; 26: 253-4.
22. Kudo M, Ikekubo K, Yamamoto K et al. Distinction between hemangioma of the liver and hepatocellular carcinoma: Value of labeled RBC-SPECT scanning. Am J Roentgenol 1989; 152: 977.
23. Yamamoto Y, Yoshida S, Sawada A et al. The analysis of Tc-99m RBCs time activity curve on liver tumor - differentiation between hemangioma and hepatocellular carcinoma. Kaku Igaku 1989; 26: 1567-73. (In Japanese.)
24. Ranke EJ. Eosinophilia and hepatocellular carcinoma: Report of a case. Am J Dig Dis 1965; 10: 548-53.
25. Komai K, Wada K, Sakata Y et al. [Eosinophilia and hepatocellular carcinoma associated with von Recklinghausen's disease.] Nippon Shokakibyo Gakkai Zasshi (Jpn J Gastroenterol) 1984; 81: 3019-22. (In Japanese.)
26. Salame M, Rickaert F, Deprez C, Van Gossum A, Cremer M. [Hepatocarcinoma and hypereosinophilia.] Acta Gastroenterol Belg 1988; 51: 169-72. (In French.)
27. Yuen BH, Reyes CV, Rawal PA, Sosman J, Jensen J. Severe eosinophilia and hepatocellular carcinoma: An unusual association. Diagn Cytopathol 1995; 13: 151-4.
28. Chang WC, Liaw CC, Wang PN, Tsai YH, Hsueh S. Tumor-associated hypereosinophilia: Report of four cases. Changgeng Yi Xue Za Zhi 1996; 19: 66-70.
29. Balian A, Bonte E, Naveau S et al. Intratumoral production of interleukin-5 leading to paraneoplastic peripheral eosinophilia in hepatocellular carcinoma. J Hepatol 2001; 34: 355-6.
30. Villas JM, Salah SA, Tovar JC, Carreter de Granda E, Guilen FS. Peripheral hypereosinophilia in a patient with hepatocellular carcinoma. South Med J 2003; 96: 326-7.
31. Bonaventure C, Etienne-Mastroianni B, Alessio A, Scoazec JY, Boillot O, Dumortier J. [Paraneoplastic hypereosinophilia associated with hepatocellular carcinoma.] Gastroenterol Clin Biol 2003; 27: 1167-9. (In French.)
32. Wasserman SI. Tumor-associated eosinophilotactic factor. N Engl J Med 1974; 290: 420.
33. Nagy K, Marschalko M, Kemeny B, Horvath A. Localization of human T-cell lymphotropic virus-1 gag proviral sequences in dermato-immunological disorders with eosinophilia. Acta Microbiol Immunol Hung 2005; 52: 385-96.
34. Penido C, Costa KA, Costa MF, Pereira Jde F, Siani AC, Henriques MG. Inhibition of allergen-induced eosinophil recruitment by natural tetranortriterpenoids is mediated by the suppression of IL-5, CCL11/ eotaxin and NFkappaB activation. Int Immunopharmacol 2006; 6: 109-21.
35. Iwasaki K, Torisu M, Fujimura T. Malignant tumor and eosinophilis, prognostic significance in gastric cancer. Cancer 1986; 58: 1321-7.
36. Kataoka S, Konishi Y, Nishio Y, Fujikawa-Adachi K, Tominaga A. Antitumor activity of eosinophils activated by IL-5 and eotaxin against hepatocellular carcinoma. DNA Cell Biol 2004; 23: 549-60.
37. Kokubun M, Kuroda M, Takagi T et al. Eosinophilia in primary biliary cirrhosis. Nippon Shokakibyo Gakkai Zasshi (Jpn J Gastroenterol) 1990; 87: 1410-16. (In Japanese.)
38. Yamazaki K, Nakadate I, Suzuki K, Sato S, Masuda T. Eosinophilia in primary biliary cirrhosis. Am J Gastroenterol 1996; 91: 516-22.
39. Terasaki S, Nakanuma Y, Yamazaki M, Unoura M. Eosinophilic infiltration of the liver in primary biliary cirrhosis: A morphological study. Hepatology 1993; 17: 206-12.
40. Yamazaki K, Suzuki K, Nakamura A et al. Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis. Hepatology 1999; 30: 71-8.